Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ketone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104936938B reveals efficient asymmetric hydrogenation reducing catalyst usage. Enhances supply chain reliability for vitamin intermediates manufacturing.
Patented hydrogen-bond resolution method for 2,3:6,7-dibenzobicyclo[3.3.1]octa-2,6-diene-4,8-dione. Achieves 99.9% ee and 55% total yield, offering superior cost efficiency for pharmaceutical manufacturing.
Patent CN109748841B details a metal-free organocatalytic route for chiral beta-aminoketones. This method offers high enantioselectivity and cost reduction in API manufacturing.
Patent CN102249976B discloses a scalable route to (-)-clausenamide using fructose-derived catalysts, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112279765B details a novel NHC-catalyzed kinetic resolution for chiral alpha-fluoroketones, offering mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Patent CN103553931A reveals a novel organocatalytic route for chiral diketones, delivering high enantioselectivity and yield for efficient steroid and terpenoid synthesis.
Patent CN114456207B reveals a green visible light nickel catalyzed method for chiral beta-aryl ketones, offering cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN106146448A reveals efficient synthesis of chiral alpha-fluoro beta-amino ketones. Discover cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN117049955B enables high-purity chiral ketone production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104513117B details copper-catalyzed asymmetric decarboxylation for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharma manufacturing.
Patent CN102898342A details a novel chiral hydroxyl amide synthesis offering 99% conversion in catalysis. Discover cost-effective manufacturing and supply advantages.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Discover how metal-free photoredox catalysis enables high-yield, enantioselective synthesis of chiral thiochroman-4-ketones for anticancer drug development. Reduce supply chain risks and GMP compliance costs.
Solve low enantioselectivity in copper-catalyzed trifluoromethylation with novel quinoline-bisoxazoline ligands. Achieve >95% ee and 70% yield for chiral beta-trifluoromethyl ketones. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.